Searchable abstracts of presentations at key conferences in endocrinology

ea0024oc2.4 | Oral Communications 2 (Brief Communications) | BSPED2010

Morbidity and Mortality of Infants with Salt Wasting Congenital Adrenal Hyperplasia in an Unscreened Population

Hird B E , Patel L , Tobi S , Clayton P E

Due to the non-specificity of symptoms in male neonates affected by salt-wasting (SW) CAH, it is hypothesised that a proportion die prior to diagnosis in countries lacking a newborn screening (NBS) programme, such as the UK. The aim of this study was to analyse 17-hydroxyprogesterone (17-OHP) in stored NBS blood spot samples, to detect undiagnosed cases of CAH. Samples were retrieved from storage for neonates who were born between 1994 and 2006, who subsequently died before 7 ...

ea0019p330 | Steroids | SFEBES2009

Glucocorticoid regulation of 11β-hydroxysteroid dehydrogenase type 1 in dermal fibroblasts

Tiganescu A , Dekker P , Mayes A E , Stewart P , Walker E A

Topical glucocorticoid therapy causes adverse effects in human skin including a reduction in dermal fibroblast proliferation and extracellular matrix protein secretion (e.g. collagen 1) and epidermal thinning – effects paralleled in photoexposed and elderly skin. These cause reduced wound healing rates and a loss of elasticity with increased fragility and transepidermal water loss – signs also typical of Cushing’s syndrome characterised by raised circulating cor...

ea0016p259 | Diabetes and cardiovascular diseases | ECE2008

Obestatin inhibits high glucose-induced reactive oxygen species production and apoptosis in bovine aortic endothelial cells

Arnoletti E , Granata R , Alloatti G , Ghigo E , Muccioli G

Endothelial dysfunction is thought to be a major cause of vascular complications in diabetes. Our research shows that obestatin, a 23-aminoacid amidated peptide recently identified as a product of the ghrelin gene, inhibited high glucose-induced apoptosis in cultured bovine aortic endothelial cells (BAEC). Exposure to high glucose concentration (30 mM) for 72 h caused a significant increase in apoptosis, as evaluated by Hoechst staining, but co-treatment of rat obestatin (from...

ea0011p132 | Clinical case reports | ECE2006

49,XXXXY syndrome connected with hypothyroidism

Wikiera B , Slezak R , Glab E , Barg E , Noczynska A

49,XXXXY syndrome is a rare defect of sex chromosomes frequently labelled as Klinefelter variant. It is associated with more severe dysmorphic features, hypogenitalism and mental retardation.The goal: To describe clinical, biochemical, hormonal, radiological and developmental status of the patient with 49,XXXXY karyotype.Report of the patient: 12-month-old boy referred because of underdeveloped genitalia. The patient was born by ca...

ea0011p706 | Reproduction | ECE2006

Functional characterization of the follicle-stimulating hormone receptor core promoter: applying a comparative approach among primates

Brune M , Kostova E , Nieschlag E , Gromoll J

Follicle-stimulating hormone (FSH) is essential for primate reproduction, acting via the FSH-receptor (FSHR) which is expressed in Sertoli and granulosa cells only. Despite its highly specific expression pattern, knowledge of the FSHR promoter and transcriptional regulation is still very limited. To gain insights into the regulatory elements controlling FSHR expression we characterized the core promoter activity of all important primate lineages including human. We isolated DN...

ea0011p708 | Reproduction | ECE2006

Androgenic status is influenced by AR polymorphism (CAG repeats number)

Canale D , Caglieresi C , Moschini C , Macchia E , Martino E

Exon 1 of AR gene contains a variable number of CAG triplets, which encode a polyglutamine stretch of variable length in the N-terminal domain of the receptor. Experimental evidence has accumulated in demonstrating that the length of this stretch influences AR transcriptional activity and therefore modulates target organs responsiveness to androgens. Aim of our study was to evaluate CAG repeats length [(CAGr)n] in various conditions hypothetically influenced by AR function. 35...

ea0009p150 | Thyroid | BES2005

Antisense chemoradioimmunotherapy consisting of antiEGFscFv linked onto high energy radioisotopes,vinorelbine and 21-nucleotide double stranded siRNA targeted to DNMT1 induce apoptosis in anaplastic thyroid CCCa characterised by hypermethylated oncosuppressor Gadd45 promoter CpG islands and overexpression of bcl-2,VEGF and Raf-1

Giannios J , Lambrinos P , Michailakis E , Maragudakis E , Alexandropoulos N

Introduction:There is a great need for targeted and tailored treatment strategies in anaplastic thyroid cancer patients.The current conventional treatment strategies consisting of surgery,chemo- or radiotherapy have a palliative effect leading to short survival periods.The failure of tumor cells to undergo apoptosis may cause resistance to chemoradiological therapies due to overexpression of antiapoptotic oncogenes and transcriptionally repressed apoptotic tumour suppressor ge...

ea0009p158 | Thyroid | BES2005

Pegylated-liposomal formulation of chimeric LNA/DNA antisense oligonucleotides against DNA MeTase and vinorelbine induces apoptosis in anaplastic thyroid cancer characterised by 5'CpG island methylation of TSGs Gadd45,p53 and Rb

Giannios J , Lambrinos P , Michailakis E , Maragudakis E , Alexandropoulos N

Introduction:Anaplastic thyroid carcinoma has a very poor prognosis because it is a highly aggressive and extremely lethal human cancer with poor therapeutic responses due to intrinsic resistance to chemotherapy.One of the reasons is DNA methylation which causes silencing of tumour suppressor genes (TSGs).To improve the prognosis of patients with anaplastic thyroid Ca,a better understanding of the molecular changes involved in its pathogenesis is essential.<p class="abstex...

ea0007oc26 | Endocrine tumours | BES2004

Mechanisms of HER2 resistance in endocrine tumours

Myers E , Hill A , McDermott E , O'Higgins N , Young L

Introduction: Regulation of HER2 through the transcription factor PEA3 is associated with tumour progression and resistance to endocrine treatment in human breast cancer. The mechanism of this resistance remains unclear. Activation of estrogen receptor co-activator proteins via the MAP-kinase pathway is thought to be central to tamoxifen insensitivity. We hypothesised that activation of HER2 by PEA3 may result in activation of co-activator proteins such as AIB1 (amplified-in-b...

ea0007p289 | Clinical case reports | BES2004

A case of non-classical 11-beta hydroxylase deficiency

Freel E , Wallace M , Fraser R , Davies E , Connell J

A 33 year old male was referred with poorly controlled hypertension. He gave no other past medical or family history. Despite therapy with multiple agents blood pressure was poorly controlled at 200/130 mm/Hg. Initial investigations which included renal ultrasound, magnetic resonance angiography and urine catecholamine excretion were all negative. Plasma renin concentration was suppressed (1 mu/ml/L, normal range 5 to 50) and plasma aldosterone was raised at 650 pmol/L (normal...